URINARY BLADDER CANCER, MUSCLE-INVASIVE

Clinical trials for URINARY BLADDER CANCER, MUSCLE-INVASIVE explained in plain language.

Never miss a new study

Get alerted when new URINARY BLADDER CANCER, MUSCLE-INVASIVE trials appear

Sign up with your email to follow new studies for URINARY BLADDER CANCER, MUSCLE-INVASIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Immunotherapy combo aims to boost bladder cancer surgery outcomes

Disease control Ongoing

This phase 3 trial tests whether adding two immunotherapy drugs—pembrolizumab and enfortumab vedotin—before and after bladder removal surgery helps people with muscle-invasive bladder cancer live longer without the cancer coming back. The study includes patients who cannot take o…

Matched conditions: URINARY BLADDER CANCER, MUSCLE-INVASIVE

Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC

URINARY BLADDER CANCER, MUSCLE-INVASIVE

Get alerted when new URINARY BLADDER CANCER, MUSCLE-INVASIVE trials appear

Immunotherapy combo aims to boost bladder cancer surgery outcomes